SCHEMBL1032622

SCHEMBL1032622

COc1ccc(Cl)cc1-c1ccnc(NC2CCC(F)(F)CC2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 4/20 0.49
MAPK14 Q16539 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
IKBKB O14920 3/20 0.45
MAPK8 P45983 4/20 0.44
MAPK9 P45984 3/20 0.44
EIF2AK2 P19525 1/20 0.44
IDH1 O75874 3/20 0.43
IDH2 P48735 2/20 0.43
AGPAT2 O15120 1/20 0.43
CDK4 P11802 2/20 0.42
GSK3B P49841 1/20 0.42
KCNH2 Q12809 1/20 0.42
HDAC8 Q9BY41 3/20 0.41
BCL6 P41182 1/20 0.41
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNA2 P20248 1/20 0.40
CCND1 P24385 1/20 0.40
CDK2 P24941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1033717 0.91 SMN1; SMN2 (0.48) MAPK10SMN1; SMN2IKBKBMAPK8MAPK9
SCHEMBL1034516 0.88 SMN1; SMN2 (0.60) MAPK10SMN1; SMN2IKBKBMAPK8MAPK9
SCHEMBL1032136 0.87 SMN1; SMN2 (0.62) MAPK10SMN1; SMN2IKBKBMAPK8MAPK9
SCHEMBL3620677 0.87 SMN1; SMN2 (0.62) MAPK10SMN1; SMN2IKBKBMAPK8MAPK9
SCHEMBL3654146 0.86 SMN1; SMN2 (0.53) MAPK10SMN1; SMN2IKBKBMAPK8MAPK9
SCHEMBL12955857 0.86 SMN1; SMN2 (0.53) MAPK10SMN1; SMN2IKBKBMAPK8MAPK9
SCHEMBL1032761 0.80 IKBKB (0.49) MAPK10SMN1; SMN2IKBKBMAPK8MAPK9
SCHEMBL1031273 0.79 HDAC8 (0.56) HDAC8
SCHEMBL1074198 0.78 IKBKB (0.47) SMN1; SMN2IKBKBMAPK8MAPK9CDK4
SCHEMBL1032457 0.77 NOS3 (0.55) SMN1; SMN2IKBKBMAPK8MAPK9CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed